Pharmacoepidemiology in the postmarketing assessment of the safety and efficacy of drugs in older adults

Sarah N. Hilmer, Danijela Gnjidic, Darrell R. Abernethy

Research output: Contribution to journalArticle

Abstract

Much of the information on safety and efficacy of drugs in older people is obtained after marketing. Pharmacoepidemiologic studies play an increasing role in obtaining this information. Pharmacoepidemiologic studies contribute significantly to knowledge of risks associated with medicines in older people and less so to that of benefits. Recent improvements in methodology in both pharmacoepidemiology and geriatric medicine have improved the validity and reduced the bias of these studies. Pharmacoepidemiologic studies are a critical component of assessing the risks of medicines in older people. Where possible, findings of pharmacoepidemiologic studies should be tested with well-conducted interventional randomized trials in relevant populations of older people.

Original languageEnglish (US)
Pages (from-to)181-188
Number of pages8
JournalJournals of Gerontology - Series A Biological Sciences and Medical Sciences
Volume67 A
Issue number2
DOIs
StatePublished - Feb 2012
Externally publishedYes

Fingerprint

Pharmacoepidemiology
Safety
Marketing
Geriatrics
Pharmaceutical Preparations
Medicine
Population

Keywords

  • Drug safety and efficacy
  • Older adults
  • Pharmacoepidemiology

ASJC Scopus subject areas

  • Aging
  • Geriatrics and Gerontology
  • Medicine(all)

Cite this

Pharmacoepidemiology in the postmarketing assessment of the safety and efficacy of drugs in older adults. / Hilmer, Sarah N.; Gnjidic, Danijela; Abernethy, Darrell R.

In: Journals of Gerontology - Series A Biological Sciences and Medical Sciences, Vol. 67 A, No. 2, 02.2012, p. 181-188.

Research output: Contribution to journalArticle

@article{d54fc789070d48bc84d8a1ffab6c293f,
title = "Pharmacoepidemiology in the postmarketing assessment of the safety and efficacy of drugs in older adults",
abstract = "Much of the information on safety and efficacy of drugs in older people is obtained after marketing. Pharmacoepidemiologic studies play an increasing role in obtaining this information. Pharmacoepidemiologic studies contribute significantly to knowledge of risks associated with medicines in older people and less so to that of benefits. Recent improvements in methodology in both pharmacoepidemiology and geriatric medicine have improved the validity and reduced the bias of these studies. Pharmacoepidemiologic studies are a critical component of assessing the risks of medicines in older people. Where possible, findings of pharmacoepidemiologic studies should be tested with well-conducted interventional randomized trials in relevant populations of older people.",
keywords = "Drug safety and efficacy, Older adults, Pharmacoepidemiology",
author = "Hilmer, {Sarah N.} and Danijela Gnjidic and Abernethy, {Darrell R.}",
year = "2012",
month = "2",
doi = "10.1093/gerona/glr066",
language = "English (US)",
volume = "67 A",
pages = "181--188",
journal = "Journals of Gerontology - Series A Biological Sciences and Medical Sciences",
issn = "1079-5006",
publisher = "Oxford University Press",
number = "2",

}

TY - JOUR

T1 - Pharmacoepidemiology in the postmarketing assessment of the safety and efficacy of drugs in older adults

AU - Hilmer, Sarah N.

AU - Gnjidic, Danijela

AU - Abernethy, Darrell R.

PY - 2012/2

Y1 - 2012/2

N2 - Much of the information on safety and efficacy of drugs in older people is obtained after marketing. Pharmacoepidemiologic studies play an increasing role in obtaining this information. Pharmacoepidemiologic studies contribute significantly to knowledge of risks associated with medicines in older people and less so to that of benefits. Recent improvements in methodology in both pharmacoepidemiology and geriatric medicine have improved the validity and reduced the bias of these studies. Pharmacoepidemiologic studies are a critical component of assessing the risks of medicines in older people. Where possible, findings of pharmacoepidemiologic studies should be tested with well-conducted interventional randomized trials in relevant populations of older people.

AB - Much of the information on safety and efficacy of drugs in older people is obtained after marketing. Pharmacoepidemiologic studies play an increasing role in obtaining this information. Pharmacoepidemiologic studies contribute significantly to knowledge of risks associated with medicines in older people and less so to that of benefits. Recent improvements in methodology in both pharmacoepidemiology and geriatric medicine have improved the validity and reduced the bias of these studies. Pharmacoepidemiologic studies are a critical component of assessing the risks of medicines in older people. Where possible, findings of pharmacoepidemiologic studies should be tested with well-conducted interventional randomized trials in relevant populations of older people.

KW - Drug safety and efficacy

KW - Older adults

KW - Pharmacoepidemiology

UR - http://www.scopus.com/inward/record.url?scp=84856203493&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856203493&partnerID=8YFLogxK

U2 - 10.1093/gerona/glr066

DO - 10.1093/gerona/glr066

M3 - Article

C2 - 21653991

AN - SCOPUS:84856203493

VL - 67 A

SP - 181

EP - 188

JO - Journals of Gerontology - Series A Biological Sciences and Medical Sciences

JF - Journals of Gerontology - Series A Biological Sciences and Medical Sciences

SN - 1079-5006

IS - 2

ER -